Esperion Theraptc (ESPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 80,104 | 168,446 | 87,309 | 82,385 | 64,995 |
| Cost of Goods | 34,573 | 27,854 | 41,289 | 28,543 | 31,538 |
| Gross Profit | 45,531 | 140,592 | 46,020 | 53,842 | 33,457 |
| Operating Expenses | 52,685 | 56,213 | 56,268 | 47,290 | 56,091 |
| Operating Income | -6,581 | 85,233 | -9,959 | 7,095 | -22,096 |
| Interest Expense | 19,798 | 22,636 | 22,051 | 20,486 | 19,431 |
| Other Income | 1,183 | 1,075 | 677 | 666 | 1,072 |
| Pre-tax Income | -25,196 | 63,672 | -31,333 | -12,725 | -40,455 |
| Net Income Continuous | -25,196 | 61,831 | -31,333 | -12,725 | -40,455 |
| Net Income | $-25,196 | $61,831 | $-31,333 | $-12,725 | $-40,455 |
| EPS Basic Total Ops | -0.10 | 0.32 | -0.16 | -0.06 | -0.21 |
| EPS Basic Continuous Ops | -0.10 | 0.32 | -0.16 | -0.06 | -0.21 |
| EPS Diluted Total Ops | -0.10 | 0.32 | -0.16 | -0.06 | -0.21 |
| EPS Diluted Continuous Ops | -0.10 | 0.32 | -0.16 | -0.06 | -0.21 |
| EPS Diluted Before Non-Recurring Items | N/A | 0.22 | -0.16 | -0.02 | -0.21 |
| EBITDA(a) | $-5,965 | $85,900 | $-9,086 | $7,942 | $-21,371 |